EP 1094840 A1 20010502 - USE OF TEXAPHYRINS IN MACROPHAGE-MEDIATED DISEASE
Title (en)
USE OF TEXAPHYRINS IN MACROPHAGE-MEDIATED DISEASE
Title (de)
VERWENDUNG VON TEXAPHYRIN ZUR BEHANDLUNG VON MACROPHAGEN-ERMITTELTEN ERKRANKUNGEN
Title (fr)
UTILISATION DE TEXAPHYRINES DANS LES MALADIES A MEDIATION MACROPHAGIQUE
Publication
Application
Priority
- US 9915199 W 19990706
- US 11050998 A 19980706
Abstract (en)
[origin: WO0001414A1] The present invention provides methods for treating disease of a subject in need thereof by sensitizing the effects of a co-therapeutic agent in macrophages. The method comprises administering a texaphyrin and a co-therapeutic agent to the subject. Texaphyrins are provided for enhancing the cytotoxicity of therapeutic agents in macrophage-mediated disease since texaphyrins have been shown to accumulate in macrophage.
IPC 1-7
IPC 8 full level
C07D 487/22 (2006.01); A61K 31/409 (2006.01); A61K 41/00 (2006.01); A61K 45/00 (2006.01); A61K 49/00 (2006.01); A61K 51/00 (2006.01); A61P 9/00 (2006.01); A61P 29/00 (2006.01); A61P 37/06 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP KR)
A61K 31/407 (2013.01 - KR); A61K 41/0028 (2013.01 - EP); A61K 41/0038 (2013.01 - EP); A61K 41/0076 (2013.01 - EP); A61P 9/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 0001414A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0001414 A1 20000113; AR 019226 A1 20011226; AU 4860899 A 20000124; CA 2336134 A1 20000113; EP 1094840 A1 20010502; JP 2002519390 A 20020702; KR 20010079498 A 20010822; NO 20010044 D0 20010104; NO 20010044 L 20010301
DOCDB simple family (application)
US 9915199 W 19990706; AR P990103250 A 19990705; AU 4860899 A 19990706; CA 2336134 A 19990706; EP 99932263 A 19990706; JP 2000557860 A 19990706; KR 20017000150 A 20010105; NO 20010044 A 20010104